We show an overview of joint recommendations of EULAR (European League Against Rheumatism) and ERA-EDTA (European Renal Association-European Dialysis and Transplant Association) for diagnostics, treatment and monitoring of patients with lupus nephritis. The text also comments on some recent data published after these guidelines went to press.